 presenc paf-aceth stool patient pouch ileoan anastomosi pouchiti platelet-activ factor endogen phospholipid wide varieti inflammatori cell platelet-activ factor induc sever patholog chang variou organ numer potent effect bowel necrosi pouchiti understood complic ileoan pouch anastomosi patient surgeri ulcer coliti aim studi ileal fecal platelet-activ factor lyso platelet-activ factor content normal volunt patient termin ileostomi patient ileoan anastomosi patient presenc ulcer reservoir fecal sampl platelet-activ factor platelet aggreg assay materi platelet-activ factor follow inhibit platelet aggreg specif platelet-activ factor receptor antagonist BN ihb Le plessi robinson franc abolit platelet aggreg incub phospholipas lipas retent time high-perform liquid chromatographi stool platelet-activ factor content nanogram gram stool mean patient pouchiti ng/g patient normal reservoir ng/g termin ileostomi ng/g healthi control ng/g stool lyso platelet-activ factor nanogram gram stool patient pouchiti ng/g patient normal reservoir ng/g stool termin ileostomi ng/g healthi volunt ng/g patient ileoan anastomosi pouchiti platelet-activ factor product inflamm ulcer reservoir